Measured Wealth Private Client Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.9K Hold
424
– – 0.01% 330
2026
Q2
$35.9K Hold
424
– – 0.01% 373
2026
Q1
$30K Hold
424
– – 0.01% 379
2025
Q4
$33.5K Sell
424
-1
-0.2% -$79 0.01% 369
2025
Q3
$35K Buy
+425
New +$33.4K 0.01% 351
2022
Q3
– Sell
-4,562
Closed -$286K – 173
2022
Q2
$286K Buy
+4,562
New +$302K 0.13% 126
2019
Q3
– Sell
-5,534
Closed -$275K – 174
2019
Q2
$275K Sell
5,534
-1,554
-22% -$73K 0.16% 146
2019
Q1
$302K Buy
+7,088
New +$313K 0.19% 124
2018
Q4
– Sell
-9,451
Closed -$440K – 455
2018
Q3
$440K Buy
9,451
+42
+0.4% +$1.92K 0.26% 61
2018
Q2
$410K Buy
+9,409
New +$439K 0.33% 59

Other funds holding MET

Measured Wealth Private Client Group's MET Position: Q3 2026 in Review

Measured Wealth Private Client Group held its MetLife (MET) position steady in Q3 2026 at 424 shares worth $39.9K. The position accounts for 0.01% of the portfolio, ranked #330.

Measured Wealth Private Client Group first reported a position in MET in Q2 2018 and has held it in 10 quarters since. The position peaked at $440K in Q3 2018. 952 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Measured Wealth Private Client Group held 424 shares of MetLife worth $39.9K as of Q3 2026.
  • Measured Wealth Private Client Group left its MetLife share count unchanged in Q3 2026.
  • MetLife made up 0.01% of Measured Wealth Private Client Group's portfolio in Q3 2026, its #330 holding.
  • Measured Wealth Private Client Group first reported a position in MetLife in Q2 2018 and has held it in 10 quarters since.
  • Measured Wealth Private Client Group's MetLife position peaked at $440K in Q3 2018.
  • 952 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q3 2026, filed 10 Nov 2026.